glp-1 dose for diabetes Incretins: How we got here, where we're at and what is coming next GLP-1 medications were first introduced

Researchers Find Small Increased Risk of Sudden Vision Loss Associated With GLP-1 Medications While the risk is low, Rutgers researchers say patients should be aware of this potential association A medication commonly used to treat Type 2 diabetes and obesity was associated with a slight increase in risk for a rare condition involving reduced blood flow to the optic nerve that can cause sudden vision loss, according to Rutgers researchers

L-carnitine (Levocarnitine) is a Carnitine Analog

Khan et al., 2025)

Kumar, A., Wissbrock, A., Goradia, N., Bellstedt, P., Ramachandran, R., Imhof, D

I Representative Perls stain images